References

  1. Fondation Lalla Salma De Lute contre Le cancer.http://www.contrelecancer.ma/site_media/uploaded_files/RCRC_-_28_mai_2012.pdf. Accessed 05 July 2014. Google Scholar

  2. Csilla András, János Pósán, Emese Csiki, Miklós Tanyi, Zoltán Csiki et al. Occurrence of bladder metastasis 10 years after surgical removal of a primary gastric cancer. Journal of Medical Case Reports. 2013 Aug;14(7):204. PubMed | Google Scholar

  3. Pramod KS, Mukesh KV, Ranjit KD, Uttara C. Secondary signet-ring cell adenocarcinoma of urinary bladder from a gastric primary. Urol Ann. 2011 May;3(2):97-9. PubMed | Google Scholar

  4. Mostofi FK, Thompson RV, Dean AL. Mucous adenocarcinoma of the urinary bladder. Cancer. 1955 Jul-Aug;8(4):741-58. PubMed | Google Scholar

  5. Bates A, Baithun S. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology. 2000 Jan;36(1):32-40. PubMed | Google Scholar

  6. Hamy A, Letessier E, Bizouarn P, et al. Study of survival and prognostic factors in patients undergoing resection for gastric linitis plastica: a review of 86 cases. Int Surg. 1999 Oct-Dec;84(4):337-43.. PubMed | Google Scholar

  7. Otsuji E, Kuriu Y, Okamoto K, Ochiai T, Ichikawa D, Hagiwara A, Yamagishi H. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg. 2004 Sep; 188(3):327-32. PubMed | Google Scholar

  8. Webb A, Cunningham D, Scarffe JH, Harper P, Norman A et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol. 1997 Jan;15(1):261-7. PubMed | Google Scholar

  9. Cunningham D, Okines AF, Ashley S. Capecitabine and oxaliplatine for advanced Esophagogastric cancer. N Engl J Med. 2010 Mar 4; 362(9):858-9. PubMed | Google Scholar